NASDAQ: ICAD - iCAD, Inc.

Yield per half year: +63.87%
Dividend yield: 0.00%
Sector: Healthcare

iCAD, Inc.

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
0/10
0 61.47 -100% -13 -100%
P/S 2.51 33.58 -92.51%
P/BV 1.3 4.79 -72.81%
P/FCF 0 60.06 -100%
Ev/Ebitda -3.07 -17.26 -82.23%
Ev/S 1.29 22.49 -94.27%
Ev/FCF -3.59 67.63 -105.3%
E/P 0 0.0168 -100%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
0/10
-42.04 -12.31 241.63% -39.73 +5.82%
ROE -22.26 9.39 -337.04%
ROA -17.96 0.1519 -11922.18%
ROIC 0 7.63 -100%
ROS -42.96 -25.64 67.55%
ROCE -23.01 14.76 -255.92%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
10/10
-0.0633 -3.68 -98.28% -0.1334 -52.51%
Nеt Debt/Ebitda 2.91 -4.07 -171.64%
Debt/Ratio 0.0111 0.199 -94.41%
Debt/Equity 0.0121 1.67 -99.28%
Debt/Net Income -0.062 10.34 -100.6%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
0/10
0 0.5399 -100% 0 0%
Number of years of dividend growth 0 0.7368 -100%
DSI 0 0.2331 -100%
Average dividend growth 0 1.07 -100%
Average percentage for 5 years 0 0.4916 -100%
Average percentage for payments 0 43.32 -100%
Difference from average difference in sector -0.5399

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
0/10
-44.67 76.2 -158.62%
Growth impulse Ebitda in 5 years -45.74 44.75 -202.21%
Growth impulse Net Income in 5 years -64.36 -15.36 319.01%
Growth impulse FCF in 5 years -15.84 -9.39 68.69%
Growth impulse EPS in 5 years -74.33 -84.03 -11.54%
IP Score
2.93/10

Similar companies

Incyte

Amarin

ImmunoGen

DENTSPLY SIRONA

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription